These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7924827)

  • 21. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 22. Adjuvant administration modulates the process of beta-cell autoimmunity and prevents IDDM: introduction to human trials.
    Vardi P
    Diabetes Metab Rev; 1993 Dec; 9(4):317-22. PubMed ID: 7924829
    [No Abstract]   [Full Text] [Related]  

  • 23. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prophylactic insulin treatment of syngeneically transplanted pre-diabetic BB-DP rats.
    Sparre T; Sprinkel AM; Christensen UB; Karlsen AE; Pociot F; Nerup J
    Autoimmunity; 2003 Mar; 36(2):99-109. PubMed ID: 12820692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intervention with nicotinamide in pre-type 1 diabetes: the Deutsche Nikotinamid Interventionsstudie-DENIS.
    Lampeter EF
    Diabete Metab; 1993; 19(1 Pt 2):105-9. PubMed ID: 8314411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.
    Elliott RB; Chase HP
    Diabetologia; 1991 May; 34(5):362-5. PubMed ID: 1830860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of alpha-tocopherol acetate and nicotinamide at the onset of insulin dependent diabetes mellitus].
    Dedov II; Gorelysheva VA; Romanovskaia GA; Filippov IK; Smirnova OM
    Klin Med (Mosk); 1995; 73(6):40-3. PubMed ID: 8691780
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanisms of the pathogenesis of overt diabetes in NOD mouse].
    Yagi H
    Seikagaku; 1990 Oct; 62(10):1263-8. PubMed ID: 2077067
    [No Abstract]   [Full Text] [Related]  

  • 30. [Free-radical theory of etiopathogenesis of insulin-dependent diabetes mellitus].
    Ciechanowski K; Machoy Z
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):48-50. PubMed ID: 1409043
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of streptozotocin on autoimmune diabetes in NOD mice.
    Koulmanda M; Qipo A; Auchincloss H; Smith RN
    Clin Exp Immunol; 2003 Nov; 134(2):210-6. PubMed ID: 14616779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
    Muir A; Schatz DA; Maclaren NK
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention.
    Michels A; Zhang L; Khadra A; Kushner JA; Redondo MJ; Pietropaolo M
    Pediatr Diabetes; 2015 Nov; 16(7):465-84. PubMed ID: 26202050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies for preventing type I diabetes mellitus.
    Verge CF; Eisenbarth GS
    West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of nicotinamide on prevention and treatment of streptozotocin-induced diabetes mellitus in rats.
    Hu Y; Wang Y; Wang L; Zhang H; Zhang H; Zhao B; Zhang A; Li Y
    Chin Med J (Engl); 1996 Nov; 109(11):819-22. PubMed ID: 9275363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of insulin administration on beta-cell function in subjects at high risk for type I diabetes mellitus.
    Rodríguez-Villar C; Conget I; González-Clemente JM; Vidal J; Navarro P; Casamitjana R; Gomis R
    Metabolism; 1996 Jul; 45(7):873-5. PubMed ID: 8692024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of experimental autoimmune diabetes in mice by treatment with leflunomide.
    Stosic-Grujicic S; Dimitrijevic M; Bartlett RR
    Transplant Proc; 1998 Dec; 30(8):4132-3. PubMed ID: 9865323
    [No Abstract]   [Full Text] [Related]  

  • 38. Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
    Harrison LC; Honeyman MC; Steele CE; Stone NL; Sarugeri E; Bonifacio E; Couper JJ; Colman PG
    Diabetes Care; 2004 Oct; 27(10):2348-55. PubMed ID: 15451899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction, prevention, and early intervention in insulin-dependent diabetes.
    Andreani D; Di Mario U; Pozzilli P
    Diabetes Metab Rev; 1991 Mar; 7(1):61-77. PubMed ID: 1935536
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin autoimmunity: the rate limiting factor in pre-type I diabetes.
    Eisenbarth GS; Jackson RA; Pugliese A
    J Autoimmun; 1992 Apr; 5 Suppl A():241-6. PubMed ID: 1503616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.